1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CAPLIN POINT LABORATORIES LTD.

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742

Expensive Performer
Download real time

2065.30 -28.00 (-1.34%)

51.30% Gain from 52W Low

29,497 NSE+BSE Volume

NSE 09 Jun, 2025 9:47 AM (IST)

Watchlist

Portfolio

Alert

Share
18S
5W
2O
2T
15,698.7

Market Cap

High in industry
29.3

PE TTM

Below industry Median
1.7

PEG TTM

PEG TTM is much higher than 1
6.2

Price to Book

Above industry Median
1.5

Beta 1Year

Very High Volatility

Caplin Point Laboratories Ltd. - CAPLIPOINT - stock price prediction, stock forecast, target price, analyst ratings from 3 analysts

Caplin Point Laboratories Ltd. has a share price target of Rs 2472, revenue growth forecast of 15.1%, and profit growth estimate of 13.2% for FY26, based on top 3 analyst calls.

Forecaster Screeners